专利号:US-9321804-B2 优先权日:2011-03-09 标题 :Synthesis and use of anti-tumor drug LQC-Y 发明人:LEI HAIMIN 权利人:UNIV BEIJING CHINESE MEDICINE; 3D MEDICINES LTD 摘要:Disclosed are the general structural formula of LQC-Y as well as the synthesis and use thereof. Pharmacological experiments demonstrated the marked antitumor effect of such compounds. Single day administration of LQC-Y3 to mice at a maximum dose of 6000 mg/kg showed no toxicity response during the 14-day continuous observation period, indicating the high safety of the compounds, and the compounds can be used to prepare medicaments for preventing and treating carcinomas such as liver cancer, lung cancer. In the general structural formula of LQC-Y, R represents steroid compounds such as cholic acid, deoxycholic acid, ursodeoxycholic acid, chenodeoxycholic acid, and hyodeoxycholic acid and so on; triterpenoid compounds such as oleanolic acid, ursolic acid, pachymic acid, glycyrrhetinic acid and glycosides thereof and so on; emodic acid, emodin and other mono-substituted or poly-substituted structures of anthraquinone parent nucleus; baicalein, baicalin and other flavonoid; shikimic acid, mono-substituted shikimic acid or poly-substituted shikimic acid; gardenia acid and other iridoid acid derivatives; paeonol, curcumin and structural derivatives thereof.
专利号:US-2014011786-A1 优先权日:2011-03-09 标题:Synthesis and use of anti-tumor drug lqc-y
1: Xu X, Wang J, Jin X, Ma Q, Li H, Zhou Q, Chen W. Bu-Shen-Ning-Xin decoction ameliorates premature ovarian insufficiency by suppressing oxidative stress through rno_circRNA_012284/rno_miR-760-3p/HBEGF pathway. Phytomedicine. 2024 Jul 29;133:155920. doi: 10.1016/j.phymed.2024.155920. Epub ahead of print. 77(6):ovae054. doi: 10.1093/lambio/ovae054. 7(1):666. doi: 10.1038/s42003-024-06323-1. 4: Li X, He A, Liu C, Li Y, Luo Y, Xiong W, Nian W, Zuo D. Pachymic acid activates TP53INP2/TRAF6/caspase-8 pathway to promote apoptosis in renal cell carcinoma cells. Environ Toxicol. 2024 Apr 1. doi: 10.1002/tox.24195. Epub ahead of print. 24(1):352. doi: 10.1186/s12903-024-04108-w. 6: Wu T, Hou W, Li S, Liu C, Zhang Y. Integrated analysis and separation of 5-lipoxygenase inhibitors from triterpenes of Poria cocos using bioaffinity ultrafiltration UPLC-Q-Exactive, molecular docking and target-based multiple complex networks. Fitoterapia. 2024 Jun;175:105856. doi: 10.1016/j.fitote.2024.105856. Epub 2024 Feb 12.
合成参考文献
参考文献:10.1248/cpb.6.608 摘要:Shibata S, Natori S, Fujita K, Kitagawa I, Watanabe K. Metabolic Products of Fungi. XV. Pachymic Acid, a Constituent of"Bukuryo"(Fu Ling ), a Sclerotium of Poria cocos (SCHW.) WOLF. Chem. Pharm. Bull. 1958;6(6):608–11. doi: 10.1248/cpb.6.608. 参考文献:10.1071/ch9710609 摘要:Pinhey J, Ralph B, Simes J, Wootton M. Extractives of fungi. II. The constituents of Trametes feei . 6α-Hydroxypolyporenic acid C. 1971 Mar 01;24(3):609–19. doi: 10.1071/ch9710609.